Ryan Specialty EPS RYAN
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2026
- $0.72
- Latest quarter, Q2 FY26
- $0.33
- −13% on a year earlier
- Fiscal year 2025
- $0.42
- −18% on the year before
Ryan Specialty's earnings per share was $0.72 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.33, down 13% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.42 | −18% |
| FY2023 | $0.51 | +16% |
| FY2022 | $0.44 | n/a |
| FY2021 | −$0.07 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.33 | −13% | $0.72 | |
| Q1 FY26 | $0.13 | n/a | $0.77 | |
| Q4 FY25 | $0.06 | n/a | $0.42 | |
| Q3 FY25 | $0.20 | +122% | n/a | |
| Q2 FY25 | $0.38 | +3% | n/a | |
| Q1 FY25 | −$0.22 | −269% | n/a | |
| Q3 FY24 | $0.09 | n/a | $0.77 | |
| Q2 FY24 | $0.37 | +42% | $0.64 | |
| Q1 FY24 | $0.13 | +18% | $0.53 | |
| Q4 FY23 | $0.18 | +157% | $0.51 | |
| Q3 FY23 | −$0.04 | −144% | $0.40 | |
| Q2 FY23 | $0.26 | +18% | $0.53 |
Against its peers
Companies in Insurance - Brokers nearest Ryan Specialty's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| RYANRyan Specialty | $0.72 | |
| ERIEErie Indemnity | $11.04 | −8% a year |
| ACTEnact | $4.75 | +8% a year |
| HGTYHagerty | $0.06 | −73% a year |
| BROBrown & Brown | $3.35 | −3% a year |
| CRVLCorvel | $2.25 | +16% a year |
| WTWWillis Towers Watson Public | $16.30 | +806% a year |
| NPNeptune Insurance | $0.31 | |
| AONAon | $18.14 | +52% a year |
| AJGArthur J. Gallagher | $6.03 | −9% a year |
| GSHDGoosehead Insurance | $1.22 | +28% a year |
| Peer median | $4.05 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Ryan Specialty
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.